Arantxa Isla
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
- Pharmacology 41
- Antibiotics Pharmacokinetics and Efficacy 40
-
- Antibiotic Resistance in Bacteria 18
- Co-authors
- Alicia Rodríguez‐Gascón (41 shared papers)Maria Ángelés Solinís (33 shared papers)Eduardo Asín‐Prieto (9 shared papers)Javier Maynar (18 shared papers)Andrés Canut (20 shared papers)José Luís Pedraz (13 shared papers)Helena Barrasa (11 shared papers)José Ángel Sánchez‐Izquierdo (9 shared papers)
In The Last Decade
Arantxa Isla
56 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Applied Microbiology and Biotechnology 200
- Molecular Medicine 393
- Pharmacology 951
- Nephrology 185
- Clinical Biochemistry 129
Countries citing papers authored by Arantxa Isla
This map shows the geographic impact of Arantxa Isla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arantxa Isla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arantxa Isla more than expected).
Fields of papers citing papers by Arantxa Isla
This network shows the impact of papers produced by Arantxa Isla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arantxa Isla. The network helps show where Arantxa Isla may publish in the future.
Co-authors
The 25 scholars most cited alongside Arantxa Isla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 188 | |
| 2 | 2018 | 151 | |
| 3 | Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy. | 1996 | 83 |
| 4 | 2021 | 80 | |
| 5 | 2017 | 67 | |
| 6 | 2005 | 59 | |
| 7 | 2013 | 58 | |
| 8 | 2008 | 57 | |
| 9 | 2005 | 49 | |
| 10 | 2005 | 47 | |
| 11 | 2013 | 43 | |
| 12 | 2020 | 36 | |
| 13 | 2005 | 34 | |
| 14 | 2018 | 34 | |
| 15 | 2012 | 33 | |
| 16 | 2012 | 32 | |
| 17 | 2015 | 31 | |
| 18 | 1997 | 30 | |
| 19 | 2020 | 27 | |
| 20 | 2007 | 27 |
About Arantxa Isla
Arantxa Isla is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 59 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (40 papers), Antibiotic Resistance in Bacteria (18 papers), Antibiotic Use and Resistance (12 papers), Pneumonia and Respiratory Infections (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Urinary Tract Infections Management (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (200 citations), Molecular Medicine (393 citations), Pharmacology (951 citations), Nephrology (185 citations) and Clinical Biochemistry (129 citations). Arantxa Isla has collaborated with scholars based in Spain, Chile and France. Frequent co-authors include Alicia Rodríguez‐Gascón, Maria Ángelés Solinís, Eduardo Asín‐Prieto, Javier Maynar, Andrés Canut, José Luís Pedraz, Helena Barrasa, José Ángel Sánchez‐Izquierdo, Iñaki F. Trocóniz and Esther Corral. Their work appears in journals such as Pharmaceutics, International Journal of Antimicrobial Agents, European Journal of Clinical Pharmacology, Clinical Pharmacokinetics and Blood Purification.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.